WHO supports self-managed medical abortion up to 12 weeks

WHO recommends that individuals up to 12 weeks pregnant can self-administer medical abortion without direct supervision of a health-care provider.

by Hazal Atay*

Abortion is one of the most common medical procedures performed worldwide. According to the World Health Organization (WHO) each year 56 million induced abortions occur. Abortion is essential healthcare and access to abortion is an important part of sexual and reproductive health services.

Worldwide, an estimated shortage of 18 million health workers is anticipated by 2030. Nonetheless, at least 400 million people worldwide lack access to the most essential health services. Access to essential and relevant healthcare is more challenging in humanitarian settings and pandemics, as healthcare institutions are disrupted and/or overloaded.

WHO consolidated guidelines on self-care interventions for “evidence-based, quality drugs, devices, diagnostics and/or digital products which can be provided fully or partially outside of formal health services and can be used with or without the direct supervision of health care personnel.” Recommending self-management of medical abortion, WHO puts forward that it is safe, feasible and acceptable.

The self-management of abortion is non-invasive and cost-effective, and it also improves autonomy as individuals might value the sense of control over their bodies and the abortion process, as well as the ability to maximize comfort being at their homes while taking pills.

Self-management can also be appealing for several practical reasons, WHO suggests, including lower costs, ease of scheduling, reduced transport needs, ability to manage stigma, and quicker termination of pregnancy.

In the same spirit, WHO in its interim guide for Maintaining essential health services: operational guidance for the COVID-19 context  recommends expanding telemedicine mechanisms for safe abortion provision, to reduce barriers that could delay care, and to minimize facility visits and provider–client contact.

Research has shown that success rate and safety outcomes for abortion through telemedicine are similar to those for in-person abortion care. Operating as a telemedicine referral service since 2005, Women on Web aims to help women and pregnant people around the world to obtain and self-manage medical abortion. Our service also works towards reducing the mortality and morbidity related to complications of unsafe abortion.

*Hazal Atay is a researcher at Sciences Po Paris and coordinator at Women on Web, working on biopolitics and sexuality with a focus on safe abortion.

Last Updated: 22/02/2021

Quick Links

위민온웹은 페미니스트 가치에 공감하며, 이에 기반한 단체입니다.

단체로서 위민온웹은 누구나 존엄성을 가지고 임신중지에 접근할 수 있는 더 나은 미래를 위해 노력합니다.

임신중지 약물에 대한 모든 것

임신중지약물인 미페프리스톤과 미소프로스톨에 대해 알아야 할 사항은 다음과 같습니다. 이 약물은 안전하고 저렴하며, 택배로 받아볼 수 있습니다.

다른 질문이 있으신가요?

모든 정보는 최근 과학적 리서치에 의해 정기적으로 업데이트 되고 있습니다.

당신의 도움으로 위민온웹의 활동이 가능해집니다

90유로를 기부하시면 기부금을 스스로 낼 형편이 되지 않는 임산부 한 명에게 서비스를 제공할 수 있습니다. 기부 외에도 위민온웹 네트워크에 가입하고 공동활동에 참여할 수도 있습니다.